Skip to main content
Sino Medical Sciences Technology Inc. logo

Sino Medical Sciences Technology Inc. — Investor Relations & Filings

Ticker · 688108 ISIN · CNE100003NY2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2026-03-30 Governance Information
Country CN China
Listing Shanghai Stock Exchange 688108

About Sino Medical Sciences Technology Inc.

https://www.sinomed.com/

Sino Medical Sciences Technology Inc. (SINOMED) specializes in the research, development, and manufacturing of high-end interventional medical devices. The company focuses on cardiovascular, neurovascular, and structural heart disease treatments. Its core product portfolio includes drug-eluting stents (DES) and balloon catheters, notably the BuMA and BuMA Supreme series. SINOMED utilizes proprietary technologies, such as the eG™ coating, to improve clinical outcomes and patient safety. The company maintains a strong commitment to clinical research and international expansion, aiming to provide innovative solutions for minimally invasive procedures.

Recent filings

Filing Released Lang Actions
赛诺医疗科学技术股份有限公司董事会议事规则（H股发行并上市后适用）
Governance Information Classification · 100% confidence The document is titled "董事会议事规则" which translates to "Board Meeting Rules" or "Rules of Procedure for the Board of Directors". It details the composition, powers, responsibilities, meeting procedures, committees, and governance practices of the company's board of directors. It references relevant laws and regulations, outlines the duties of the board and its committees, and specifies procedural rules for board meetings. There is no financial data, audit information, or report content. Instead, it is a governance document describing internal rules and structure of the board. Therefore, this document fits the category of Governance Information (CGR). The document length is substantial and it is not an announcement or a brief notice, so it is not an RPA or RNS. Hence, the classification is CGR with high confidence.
2026-03-30 Chinese
赛诺医疗关于修订及制定公司于 H 股发行上市后适用《公司章程（草案）》及相关议事规则、部分公司治理制度的公告
Governance Information Classification · 95% confidence The document is a detailed announcement from the board of directors of 赛诺医疗科学技术股份有限公司 regarding the revision and formulation of the company's Articles of Association (Company Charter) and related governance rules applicable after the company's H-share issuance and listing on the Hong Kong Stock Exchange. It includes extensive details on corporate governance, shareholder rights, board responsibilities, and compliance with relevant laws and listing rules. The document is not a financial report, earnings release, or audit report, nor is it a simple announcement of voting results or a proxy solicitation. Instead, it is a governance-related disclosure focusing on the company's internal rules and governance practices. Therefore, the most appropriate classification is Governance Information (CGR). The document length (15,000 characters) and content confirm it is a substantive governance report, not a brief announcement or certification.
2026-03-30 Chinese
赛诺医疗科学技术股份有限公司关于续聘2026年度审计机构的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the reappointment of the audit firm (立信会计师事务所) for the fiscal year 2026. It details the audit firm's background, qualifications, personnel, independence, and the procedures followed by the board and independent directors to approve the reappointment. It explicitly states that the reappointment still requires shareholder approval. The document does not contain any actual audit report, financial statements, or audit results. Instead, it is a formal announcement about the selection and continuation of the audit firm for the upcoming year. Therefore, it is not an audit report itself (AR) nor an annual report (10-K), but an announcement related to audit services. This fits the category of Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2026-03-25 Chinese
赛诺医疗科学技术股份有限公司2025年度独立董事述职报告（高岩）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Annual Report" for the year 2025 by Gao Yan, an independent director of the company. It details the director's background, attendance at board and committee meetings, exercise of duties, communication with auditors, oversight of financial reporting and internal controls, and evaluation of governance and compliance matters during the year. It also discusses specific corporate governance activities such as board member changes, audit committee activities, and responses to accounting errors and regulatory communications. The document is a detailed report on the independent director's annual duties and oversight activities rather than a full annual report or audit report. It is not a simple announcement or certification but a substantive management/governance related report. Therefore, it fits best under the category of Board/Management Information (MANG), which includes announcements or reports related to board members and senior management activities and governance oversight.
2026-03-25 Chinese
赛诺医疗科学技术股份有限公司2025年年度报告
Annual Report Classification · 100% confidence The document is titled "赛诺医疗科学技术股份有限公司 2025 年年度报告" which translates to "Sino Medical Sciences Technology Inc. 2025 Annual Report." It contains detailed financial data for the year 2025, including revenue, net profit, cash flow, and other key financial indicators. The document includes management discussion and analysis, company overview, risk factors, governance, and detailed financial statements. It also references the audit report by an accounting firm and includes signatures from company officers guaranteeing the accuracy of the report. The length of the document is substantial (15,000 characters), and it contains comprehensive financial and operational information typical of an official annual report. There is no indication that this is merely an announcement or a summary; rather, it is the full annual report itself. FY 2025
2026-03-25 Chinese
赛诺医疗科学技术股份有限公司2025年非经营性资金占用及其他关联资金往来情况汇总表的专项审计报告
Audit Report / Information Classification · 85% confidence The document is a standalone specialized audit report (专项审计报告) issued by a certified public accounting firm on the company’s non-operating fund occupation and related‐party fund transactions for the 2025 fiscal year. It contains audit opinions, schedules, and auditor signatures, and is not the full Annual Report nor merely an announcement of a report. Therefore it fits the category for Audit Report / Information (AR). FY 2025
2026-03-25 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.